A case of carbapenemase-producing Klebsiella pneumoniae in Australia
Authors:
- Nicholas R. CoatsworthNCNicholas R. Coatsworth
- Peter G. HuntingtonPHPeter G. Huntington
- Robyn P. HardimanRHRobyn P. Hardiman
- Bernard J. HudsonBHBernard J. Hudson
- Clarence J. FernandesCFClarence J. Fernandes
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniaeJournal of Clinical Microbiology, 2010
- Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamase resistant to colistinJournal of Hospital Infection, 2010
- A risk for returned travellers: the “post‐antibiotic era”Medical Journal of Australia, 2010
- A simple phenotypic method for the differentiation of metallo- -lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolatesJournal of Antimicrobial Chemotherapy, 2010
- The real threat of Klebsiella pneumoniae carbapenemase-producing bacteriaThe Lancet Infectious Diseases, 2009
- Isolation of Imipenem-Resistant Enterobacter Species: Emergence of KPC-2 Carbapenemase, Molecular Characterization, Epidemiology, and OutcomesAntimicrobial Agents and Chemotherapy, 2008
- Tigecycline for Treatment of Pneumonia and Empyema Caused by Carbapenemase‐Producing Klebsiella pneumoniaePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Plasmid-Mediated Carbapenem-Hydrolyzing β-Lactamase KPC in a Klebsiella pneumoniae Isolate from FranceAntimicrobial Agents and Chemotherapy, 2005
- Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York CityArchives of internal medicine (1960), 2005
- Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain ofKlebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2001